---
title: "Randomised Controlled Trial to Investigate the Effect of Parental Presence at Intensive Care Unit to Ward Transfer Bedside Rounds on Parental Anxiety and Children's Safety"
nct_id: NCT01883739
overall_status: COMPLETED
phase: NA
sponsor: University of Alberta
study_type: INTERVENTIONAL
primary_condition: Parental Anxiety
countries: Canada
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01883739.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01883739"
ct_last_update_post_date: 2014-12-19
last_seen_at: "2026-05-12T07:13:47.713Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Randomised Controlled Trial to Investigate the Effect of Parental Presence at Intensive Care Unit to Ward Transfer Bedside Rounds on Parental Anxiety and Children's Safety

**NCT ID:** [NCT01883739](https://clinicaltrials.gov/study/NCT01883739)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 200
- **Lead Sponsor:** University of Alberta
- **Collaborators:** Canadian Medical Protective Association
- **Conditions:** Parental Anxiety, Children's Safety
- **Start Date:** 2013-06
- **CT.gov Last Update:** 2014-12-19

## Brief Summary

The investigators shall conduct a randomized controlled trial to investigate the effect of parental presence at transfer rounds on parental anxiety and patient safety following transfer from the Pediatric Cardiac Intensive Care Unit (PCICU) to the ward. The investigators plan to test the hypothesis that parental involvement in the child's transfer, with the option of peer support, will result in measurable reductions in medication errors, unplanned nutritional and feeding management, and parental anxiety after transfer as compared to the control group. The investigators goal is to improve continuity of care by implementing multidisciplinary transfer rounds at the child's bedside in which patients and family share in the control of the management plan when a cardiac child is discharged from PCICU to the ward.

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* Parents of cardiac children aged 1 day to 17 years admitted to PCICU
* Written informed consent and assent when appropriate
* Planned discharge from the PCICU to the ward.

Exclusion Criteria:

* Parents with less than grade 6 reading skills as they will not be able to independently take the Spielberger's State -Trait Anxiety Inventory (STAI).
* Parents who are not willing to be randomized to the control group in which they cannot be present for transfer rounds.
* Neonates being discharged from PCICU to NICU or neonates being discharged from NICU to wards.
```

## Arms

- **Parental Presence at Handover Rounds** (EXPERIMENTAL) — Subjects will receive an educational document prior to transfer rounds introducing the concept of Patient and Family Centered Care and the role of a parent in transfer rounds. These parents will have the option of meeting with a parental peer support person for a "coaching" or training session prior to their participation in transfer rounds. During the transfer rounds parents will be actively included in discussion of their child's medical management plan upon discharge to the wards.

## Interventions

- **Parental Presence at Handover Rounds** (OTHER)

## Primary Outcomes

- **Change from baseline in parental STAI score** _(time frame: 2 to 4 hours post transfer)_ — Speilberger State-Trait Anxiety Inventory will be administered to participating parents both prior to and post transfer of their child out of the pediatric cardiac ICU.

## Secondary Outcomes

- **Rate of unplanned changes in medication and nutrition management** _(time frame: 48 hours post transfer)_

## Locations (1)

- Pediatric Cardiac ICU, Stollery Children's Hospital, Edmonton, Alberta, Canada

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.pediatric cardiac icu, stollery children's hospital|edmonton|alberta|canada` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01883739.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01883739*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*